This author has yet to write their bio.Meanwhile lets just say that we are proud CAPTIS contributed a whooping 4509 entries.
Targeting this biochemical pathway may help develop new therapies for alleviating the symptoms of anxiety disorders. The lab of Prof. Mike Fainzilber in the Institute’s Biomolecular Sciences Department The post Weizmann researchers discover new neural mechanism underlying anxiety appeared first on Pharmaceutical Business review.
Zilucoplan, which is a synthetic, macrocyclic peptide, achieved clinically meaningful and statistically significant reductions across the primary and key secondary endpoints for its two dose groups in comparison The post Ra Pharma’s zilucoplan meets primary endpoints in phase 2 gMG trial appeared first on Pharmaceutical Business review.
The phase 3 trial, called ECLIPSE, enrolled 1048 patients to evaluate the efficacy and safety of Tremfya in comparison to Cosentyx. While Tremfya is an interleukin (IL)-23-targeted biologic The post Janssen’s Tremfya meets primary endpoint in phase 3 psoriasis trial appeared first on Pharmaceutical Business review.
The UK government is preparing for a “worst-case” Brexit scenario in which no deal is reached between the country and the European Union by March 29, the date the country is slated to leave the EU, according to a recent release from UK health minister Matt Hancock. Preparations include increasing the stock holding capacity in […]
Sanuwave said late last month that it lifted acting CEO and board chair Kevin Richardson to a permanent position in the corner office. Richardson joined the Suwanee, Ga.-based company in 2009 as board chair, and has served as acting CEO since 2014. He also served as managing partner of investment management firm Prides Capital from […]
The U.S. Court of Appeals for the Federal Circuit this week affirmed Stryker‘s (NYSE:SYK) enhanced $248 million win in a surgical tool patent case against Zimmer Biomet (NYSE:ZBH). The Federal Circuit court affirmed the judgement in a per curiam ruling dated on Monday, according to recently released court documents. The damages in the case were previously […]
The joint team is focused on the discovery of efficacious inhibitors of PknB, which is essential for the growth of Mycobacterium tuberculosis (TB). Schrödinger’s computational platform has led The post Schrödinger, TB Alliance collaborate to advance tuberculosis drug discovery appeared first on Pharmaceutical Business review.
Black Diamond is the first company launched out of Ridgeline, Versant’s Discovery Engine based in Basel, Switzerland, and has a unique platform capable of prosecuting allosteric mutant oncogenes. The post Versant Ventures launches new biotech firm Black Diamond Therapeutics appeared first on Pharmaceutical Business review.
Circassia has issued a notice of option exercise to AstraZeneca related to US commercial rights of Tudorza. The company intends to complete the option exercise by the end The post Circassia to acquire full US rights of AstraZeneca’s COPD treatment Tudorza appeared first on Pharmaceutical Business review.
Boston Scientific (NYSE:BSX) today claimed a win in an ongoing patent spat with Edwards Lifesciences (NYSE:EW) over transcatheter aortic valve replacement system patents. Marlborough, Mass.-based Boston Scientific said that a jury in the U.S. District Court for the District of Delaware ruled in its favor, finding that their ‘608 patent, related to a transcatheter heart valve sealing skirt, […]
Cancer is not a ‘one size fits all,’ nor is the way we treat it. We are working to better understand the different ways a cancer can mutate so we can discover new approaches to treat some of the most difficult-to-treat types of the disease. #ReimagineMedicine #ESMO18 pic.twitter.com/41QL…
Read carefully employer's directions on how to apply. #resume #resumetips
Here are 5 Tips to Avoid Back Pain from #WorldSpineDay. #Exercise #Posture #Stress #HealthyEating #Strength pic.twitter.com/AT1D…
Large-vessel giant cell arteritis: diagnosis, monitoring and management | Rheumatology | Oxford Academic academic.oup.com/rhe…
Scientists have made an unexpected discovery while investigating the triggering factors of #ColonCancer: Cell stress in combination with an altered microbiota in the colon drives tumor growth. Learn more: ow.ly/JxtK30meLTY pic.twitter.com/U51Q…
If you are in Dallas attending the AAFPRS 12th International Symposium of Facial Plastic Surgery don’t miss out on this Breakfast Symposium tomorrow morning with Dr. William Binder that is sponsored by Implantech! #implantech #superiorpatientaesthetics #implantechrewards #aafprs pic.twitter.com/HCzK…
Less than one month left to submit your science for #ACC19! Abstract & case submissions are due Oct. 16. Learn more: ow.ly/4nyf30lYZxh pic.twitter.com/Mnwv…
With #CARTcell therapy, an inactive virus programs T cells with new genetic information to help recognize specific antigens found on normal cells and certain blood cancer cells. As the CAR-T cells multiply, new copies also gain this ability. #CARTCellStory pic.twitter.com/Xuoh…
Make plans to visit the Integra LifeSciences Booth# 919 during Plastic Surgery The Meeting September 28th - October 1st. #Integra_LifeSciences #DurableIsBeautiful #PSTM18 #ASPS #PlasticSurgery pic.twitter.com/8QGv…
We are live at #NASS2018 stand 2649. Get hands-on with the world's leading surgical #simulator in #VR with #haptics and experience the future of surgical training. #wearefundamental fundamentalsurgery.c… pic.twitter.com/NgzA…
Congratulations to Lane Major for his recent promotion to Chief Operating Officer @K2MInc! Read more: bit.ly/LaneMajor pic.twitter.com/iDXk…
Great things happening at Tissue Regenix! Plan to visit our booth at the AAOS meeting in New Orleans, under the CellRight Technologies banner #5413. @AAOS1
All evaluation cases for the new Corin Dual Mobility option for the Trinity Acetabular cup system have now been completed and we're looking forward to the full launch. Click lnkd.in/g8ariEY for details #orthopaedics #technology #totalhip #uniquehip pic.twitter.com/SPsy…
Thank you to our @Medtronic employees around the globe! Q3 saw strong, balanced results, with diversified performance in all groups and regions. #MDTEarnings
#cardiovascular news CorFlow Presents Fundamental New Insights into the Coronary Microcirculation at ACC - CorFlow Therapeutics AG corflowtherapeutics.… today announced that the company will present fundamental new insights into the coronary microci... ow.ly/OlaG50gAElO
Welcome Sravan Emany, our new vice president, treasurer and head of investor relations. investor.integralife… pic.twitter.com/wzt5…
Read in this edition all about Novartis Oncology’s ground-breaking CAR-T therapy; how SwissMedic is leading the world in terms of regulatory innovation; the story of Actelion’s acquisition by J&J and the subsequent emergence of a new entity – Idorsia. pharmaboardroom.com/…
Thème du congrès SOFCOT 2018 : "La Décision Médicale" pic.twitter.com/hJT5…
Exactly 3 weeks left to submit your abstract for #EUROSPINE2018 - #deadline 1 March 2018 #research #spine #SpineResearch #spineSurgery #SpinalDisorder #ScientificPaper #BasicScience #ClinicalResearch #PublishResearch @EurSpineJournal buff.ly/2ExMQ7e pic.twitter.com/Fx2Q…
Throughout the week, we are in #Bruges alongside Prof. Jan Casselman for an #Erasmus course program on #ENT imaging, held at the Oud Sint-Jan congress centre. The training of around 170 radiologists is based on images from our post-processing solution Olea Sphere®V3.0. #MRI pic.twitter.com/KSUU…
Our very best and up-to-date selection of healthcare Industries' News (Products, Markets, Companies, R&D, Technology, Opportunities, Investment & Finance...).
Read at Healthcare News
Europe & International
+41 22 518 2100
|
Thank you for visiting our new website! Help us improve, let us know your feedback (Anonymous 2 min survey)
|
